Reply to: "Comment on: Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood"

Affiliations

¹ Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
² Centre for Rare Diseases, University of Tübingen, Tübingen, Germany.
³ Evotec SE, Hamburg, Germany.

Comment

Jeannette Hübener-Schmid et al. Mov Disord. 2022 May.

. 2022 May;37(5):1121-1122.

doi: 10.1002/mds.29003.

¹ Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
² Centre for Rare Diseases, University of Tübingen, Tübingen, Germany.
³ Evotec SE, Hamburg, Germany.

No abstract available

Comment on

Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood.
Hübener-Schmid J, Kuhlbrodt K, Peladan J, Faber J, Santana MM, Hengel H, Jacobi H, Reetz K, Garcia-Moreno H, Raposo M, van Gaalen J, Infante J, Steiner KM, de Vries J, Verbeek MM, Giunti P, Pereira de Almeida L, Lima M, van de Warrenburg B, Schöls L, Klockgether T, Synofzik M; European Spinocerebellar Ataxia Type-3/Machado-Joseph Disease Initiative (ESMI) Study Group; Riess O. Hübener-Schmid J, et al. Mov Disord. 2021 Nov;36(11):2675-2681. doi: 10.1002/mds.28749. Epub 2021 Aug 16. Mov Disord. 2021. PMID: 34397117
Comment on: Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood.
Hanna Al-Shaikh R, Jansen-West KR, Petrucelli L, Wszolek ZK, Prudencio M. Hanna Al-Shaikh R, et al. Mov Disord. 2022 May;37(5):1120-1121. doi: 10.1002/mds.29008. Mov Disord. 2022. PMID: 35587620 No abstract available.

1. Hubener-Schmid J, Kuhlbrodt K, Peladan J, et al. Polyglutamine-expanded Ataxin-3: a target engagement marker for spinocerebellar ataxia type 3 in peripheral blood. Mov Disord 2021;36(11):2675-2681.
1. Prudencio M, Garcia-Moreno H, Jansen-West KR, et al. Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3. Sci Transl Med 2020;12(566):eabb7086
1. Miller J, Arrasate M, Brooks E, et al. Identifying polyglutamine protein species in situ that best predict neurodegeneration. Nat Chem Biol 2011;7(12):925-934.
1. Klein FAC, Zeder-Lutz G, Cousido-Siah A, et al. Linear and extended: a common polyglutamine conformation recognized by three antibodies MW1, 1C2 and 3B5H10. Hum Mol Genet 2013;22(20):4215-4223.
1. Owens EG, New DM, West AP Jr, Bjorkman PJ. Anti-PolyQ antibodies recognize a short polyQ stretch in both normal and mutant huntingtin exon 1. J Mol Biol 2015;427(15):2507-2519.